Biotech | March 12, 2024
USFDA grants Orphan Drug Designation for iOnctura's first-in-class autotaxin cancer therapy
It is the first autotaxin inhibitor to be investigated in cancer patients
It is the first autotaxin inhibitor to be investigated in cancer patients
AbCellera will receive an upfront payment and is eligible to receive additional milestone payments
ANVISA issues CGMP to Concord Biotech’s Unit I
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
Cipla completes transfer of Generics Business Undertaking
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
The contract awarded to Kilitch Estro Biotech PLC entails the supply of pharmaceuticals with an order size amounting to US$ 9.13 million
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
Subscribe To Our Newsletter & Stay Updated
